NCT06079567View on ClinicalTrials.gov

An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 3, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Facioscapulohumeral Muscular Dystrophy Type 2
Interventions
DIAGNOSTIC_TEST

Validation of new COMs for FSHD2 patients

Monitoring of commonly used and new COMs in FSHD2 patients

Trial Locations (9)

3000

NOT_YET_RECRUITING

Leuven University, Leuven

13005

NOT_YET_RECRUITING

APHM, Marseille

20014

NOT_YET_RECRUITING

Donostia University Hospital, Donostia / San Sebastian

20162

NOT_YET_RECRUITING

Nemo Center, Milan

56126

NOT_YET_RECRUITING

Pisa University, Pisa

75000

NOT_YET_RECRUITING

Myology Institute, Paris

06000

RECRUITING

Nice University Hospital, Nice

00168

NOT_YET_RECRUITING

Gemelli University Hospital, Rome

Unknown

NOT_YET_RECRUITING

Radboud University Medical Centre Nijmegen, Nijmegen

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER